Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19.

Kow, Chia Siang; Ramachandram, Dinesh Sangarran; Hasan, Syed Shahzad

Kow, Chia Siang; Ramachandram, Dinesh Sangarran; Hasan, Syed Shahzad.

Kow CS; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia. chiasiang_93@hotmail.com.
Ramachandram DS; School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia. chiasiang_93@hotmail.com.
Hasan SS; School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.

High Blood Press Cardiovasc Prev ; 29(3): 313-314, 2022 05.

Article in English | MEDLINE | ID: covidwho-1750892

Subject(s)

COVID-19 Drug Treatment; Hypertension; Antihypertensive Agents/therapeutic use; Calcium Channel Blockers/therapeutic use; Humans; Hypertension/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Hypertension Limits: Humans Language: English Journal: High Blood Press Cardiovasc Prev Year: 2022 Document Type: Article Affiliation country: S40292-022-00515-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google